|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences|
|Narender Goel, Deepika Jain, Danny B. Haddad, Divya Shanbhogue|
J Stroke. 2020;22(3):306-316. Published online September 29, 2020
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
Anticoagulation for Atrial Fibrillation in Patients with End- Stage Kidney Disease
P1301CLINICAL OUTCOMES OF ORAL ANTICOAGULATION AND NO ANTICOAGULATION AMONG END-STAGE RENAL DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS WITH ATRIAL FIBRILLATION: A SINGLE-CENTER PROSPECTIVE COHORT STUDY
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response
Does the risk exceed the benefit for anticoagulation in end‐stage renal disease patients with nonrheumatic atrial fibrillation?
Use of Oral Anticoagulation for Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays?
Anticoagulation for Atrial Fibrillation in End-stage Kidney Disease
Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
Warfarin for Atrial Fibrillation in Patients With End-Stage Renal Disease